These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Beckers A; Aaltonen LA; Daly AF; Karhu A Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967 [TBL] [Abstract][Full Text] [Related]
4. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas. Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585 [TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas. Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063 [TBL] [Abstract][Full Text] [Related]
7. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395 [TBL] [Abstract][Full Text] [Related]
8. Activated AMP-protein kinase (pAMPK) is overexpressed in human somatotroph pituitary adenomas. Bizzi MF; Drummond JB; Pinheiro SVB; Paulino E; Araújo SA; Soares BS; Giannetti AV; Schweizer JROL; Barry S; Korbonits M; Ribeiro-Oliveira A Mol Cell Endocrinol; 2024 Oct; 592():112318. PubMed ID: 38908427 [TBL] [Abstract][Full Text] [Related]
9. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues. Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625 [TBL] [Abstract][Full Text] [Related]
11. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813 [TBL] [Abstract][Full Text] [Related]
13. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas. Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934 [TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465 [TBL] [Abstract][Full Text] [Related]
15. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940 [TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma. Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687 [TBL] [Abstract][Full Text] [Related]
17. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance. Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736 [TBL] [Abstract][Full Text] [Related]
18. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572 [TBL] [Abstract][Full Text] [Related]